Select Medical upgraded by The Benchmark Company with a new price target
$SEM
Hospital/Nursing Management
Health Care
The Benchmark Company upgraded Select Medical from Hold to Buy and set a new price target of $23.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/16/2025 | $25.00 | Outperform | Mizuho |
| 2/24/2025 | $23.00 | Hold → Buy | The Benchmark Company |
| 11/25/2024 | Buy → Hold | The Benchmark Company | |
| 8/20/2024 | $42.00 | Buy | BofA Securities |
| 3/7/2022 | $47.00 → $42.00 | Outperform | RBC Capital |
| 1/18/2022 | $40.00 → $35.00 | Buy | B of A Securities |
| 1/18/2022 | $50.00 → $47.00 | Outperform | RBC Capital |
| 8/10/2021 | $37.00 → $39.00 | Neutral | Credit Suisse |
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer. David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board. John A. Saich, who most recently held the position of co-president, will serve as the company's sole president. John F. Duggan has been appointed executive vice president, general counsel and secretary. The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita
MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend. For the second quarter ended June 30, 2025, revenue increased 4.5% to $1,339.6 million, compared to $1,281.7 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 17.2% to $86.5 million for the second quarter ended June 30, 2025, compared to $73.9 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 53.8% to $57.9 million for the second quar
MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on Thursday, July 31, 2025 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 1, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
Mizuho initiated coverage of Select Medical with a rating of Outperform and set a new price target of $25.00
The Benchmark Company upgraded Select Medical from Hold to Buy and set a new price target of $23.00
The Benchmark Company downgraded Select Medical from Buy to Hold
3 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer. David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board. John A. Saich, who most recently held the position of co-president, will serve as the company's sole president. John F. Duggan has been appointed executive vice president, general counsel and secretary. The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021. Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi
MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend. For the second quarter ended June 30, 2025, revenue increased 4.5% to $1,339.6 million, compared to $1,281.7 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 17.2% to $86.5 million for the second quarter ended June 30, 2025, compared to $73.9 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 53.8% to $57.9 million for the second quar
MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on Thursday, July 31, 2025 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 1, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene
MECHANICSBURG, Pa., May 1, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. For the first quarter ended March 31, 2025, revenue increased 2.4% to $1,353.2 million, compared to $1,321.2 million for the same quarter, prior year. Income from continuing operations before other income and expense was $112.7 million for the first quarter ended March 31, 2025, compared to $118.5 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 21.5% to $74.7 million for the first quarter ended March
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)